Ketorolac 10 mg Oral Dosing Regimen
For ketorolac 10 mg oral tablets, the appropriate dosing is 10 mg every 4-6 hours as needed, not exceeding 40 mg per day, and only as continuation therapy following initial IV or IM ketorolac administration, with total treatment duration (IV/IM plus oral) not exceeding 5 days. 1
Critical Dosing Parameters
Initial Dose Requirements
- Oral ketorolac should NEVER be given as the initial dose 1
- Must be preceded by IV or IM ketorolac administration
- Oral formulation serves only as continuation/transition therapy
Standard Adult Dosing (Ages 17-64)
- Transition dose: 20 mg PO once (following IV/IM dosing)
- Maintenance: 10 mg every 4-6 hours as needed
- Maximum daily dose: 40 mg/day
- Minimum dosing interval: 4-6 hours (do not shorten) 1
Dose Adjustments for High-Risk Patients
For patients ≥65 years, renally impaired, or weighing <50 kg (110 lbs):
- Transition dose: 10 mg PO once
- Maintenance: 10 mg every 4-6 hours as needed
- Maximum daily dose: 40 mg/day 1
Duration Restrictions
The combined duration of IV/IM plus oral ketorolac must not exceed 5 days in adults 1. This is a hard stop mandated by FDA labeling due to increased risks of serious adverse events with prolonged use, including:
- Gastrointestinal bleeding and perforation 2, 3
- Renal toxicity 3
- Cardiovascular events 3
- Increased bleeding risk 4, 5
Clinical Context from Guidelines
Multiple guidelines support short-term ketorolac use but emphasize caution:
- Cancer pain guidelines recommend 15-30 mg IV every 6 hours for maximum 5 days 3
- Migraine treatment uses 60 mg IM with 120 mg/day maximum for up to 5 days 2
- Perioperative settings demonstrate efficacy but require monitoring for renal and bleeding complications 4, 5, 6
Safety Monitoring Requirements
Patients on ketorolac require monitoring for:
- Renal function: Discontinue if BUN/creatinine doubles 3
- GI toxicity: Higher risk in patients >60 years, history of peptic ulcer disease, or alcohol use 3
- Bleeding: Avoid in patients with thrombocytopenia, bleeding disorders, or concurrent anticoagulation 3, 4
- Cardiovascular: Discontinue if hypertension develops or worsens 3
Common Pitfalls to Avoid
- Never use oral ketorolac as first-line therapy - it requires prior parenteral administration 1
- Never exceed 5-day total duration - this includes all routes combined
- Never shorten the 4-6 hour dosing interval - doing so increases toxicity without improving analgesia 1
- Never exceed 40 mg/day oral dose - higher doses increase adverse events without additional benefit 1
- Avoid in high-risk populations without dose adjustment: elderly, renal impairment, low body weight 1